Proactive Investors - Run By Investors For Investors

Genedrive to premiere Hepatitis C test at Asia-Pacific medical exhibition

The AIM-listed diagnostics company said the kit would make its debut at the MEDLAB Asia Pacific Exhibition & Congress in Singapore
Medical Microscope
The conference is a significant event in the region for leading companies to showcase their technologies and innovations

Genedrive PLC (LON:GDR) has said it will premiere its HCV ID Kit in the Asia-Pacific (APAC) region on 2-4 April 2018.

The AIM-listed diagnostics company said the kit would make its debut at the MEDLAB Asia Pacific Exhibition & Congress in Singapore.

READ: Genedrive extends global coverage with new distribution agreement in India

The conference, the firm said, is a significant and highly attended event in the Asia Pacific region for leading companies to showcase their technologies and innovations in the field of laboratory diagnostics. With over 4,000 delegates from around the world, the congress features products in many areas including point of need and infectious diseases.

The company’s APAC debut comes after it announced its first commercial sales of instruments and assays to Sysmex Europe GmbH to cover Europe, Middle East and Africa and Sysmex Asia Pacific Pte Ltd for the Asia Pacific region, excluding India.

View full GDR profile View Profile

Genedrive PLC Timeline

Related Articles

pippette
November 23 2018
The Australian regenerative medicine company is developing a portfolio of innovative cellular therapies targeting significant unmet medical needs with a licence-driven strategy.
scientist in lab
December 18 2018
VAL401 is ValiRx’s most advanced compound, with earlier trial results suggesting it can improve quality of life and chances of survival of lung cancer patients
man and woman working in a lab
October 11 2018
There were no adverse safety findings and excellent drug-like properties were confirmed.

© Proactive Investors 2019

Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use